67 67 Soeda T, Uemura S, Park SJ, et al. Incidence and clinical significance of poststent optical coherence tomography findings: one‐year followup study from a multicenter registry. Circulation 2015; 132:1020–9.
68 68 Secco GG, Foin N, Viceconte N, et al. Optical coherence tomography for guidance of treatment of in‐stent restenosis with cutting balloons. EuroIntervention 2011; 7(7): 828–834.
69 69 Mattesini A, Pighi M, Konstantinidis N, et al. Optical coherence tomography in bioabsorbable stents: mechanism of vascular response and guidance of stent implantation. Minerva Cardioangiol 2014; 62(1): 71–82.
70 70 Hong M‐K, Mintz GS, Lee CW, et al. Late stent malapposition after drug‐eluting stent implantation: an intravascular ultrasound analysis with long‐term follow‐up. Circulation 2006; 113(3): 414–419.
71 71 Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug‐eluting stent implantation. Circulation 2007; 115(18): 2426–2434.
72 72 Hassan AKM, Bergheanu SC, Stijnen T, et al. Late stent malapposition risk is higher after drug‐eluting stent compared with bare‐metal stent implantation and associates with late stent thrombosis. Eur Heart J 2010; 31(10): 1172–1180.
73 73 Im E, Kim BK, Ko YG, et al. Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drugeluting stent implantation. Circ Cardiovasc Interv 2014; 7(1): 88–96.
74 74 Gutiérrez‐Chico JL, Wykrzykowska J, Nüesch E, et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv 2012; 5(1): 20–9, S1–8.
75 75 Adriaenssens T, Joner M, Godschalk T, et al. Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Investigators. Optical coherence tomography findings in patients with coronary stent thrombosis: a report of the PREvention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Consortium. Circulation 2017; 136:1007–1021.
76 76 Souteyrand G, Amabile N, Mangin L, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J 2016; 37: 1208–1216.
77 77 Taniwaki M, Radu MD, Zaugg S, et al. Mechanisms of very late drug‐eluting stent thrombosis assessed by optical coherence tomography. Circulation 2016; 133:650–660.
78 78 Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug‐eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007; 115(18): 2435–2441.
79 79 Joner M, Finn AV, Farb A, et al. Pathology of drug‐eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48(1): 193–202.
80 80 Gutiérrez‐Chico JL, van Geuns RJ, Regar E, et al. Tissue coverage of a hydrophilic polymer‐coated zotarolimus‐eluting stent vs a fluoropolymer‐coated everolimuseluting stent at 13‐month follow‐up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 2011; 32(19): 2454–2463.
81 81 Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart 2009; 95(23): 1913–1919.
82 82 Gonzalo N, Serruys PW, Okamura T, et al. Relation between plaque type and dissections at the edges after stent implantation: an optical coherence tomography study. Int J Cardiol 2011; 150(2): 151–155.
83 83 Tyczynski P, Ferrante G, Moreno‐Ambroj C, et al. Simple versus complex approaches to treating coronary bifurcation lesions: direct assessment of stent strut apposition by optical coherence tomography. Rev española Cardiol 2010; 63(8): 904–914.
84 84 Viceconte N, Tyczynski P, Ferrante G, et al. Immediate results of bifurcational stenting assessed with optical coherence tomography. Catheter Cardiovasc Interv 2013; 81(3): 519–528.
85 85 Lassen JF, Holm NR, Stankovic G, et al. Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. EuroIntervention 2014; 10(5): 545–560.
86 86 Alegría‐Barrero E, Foin N, Chan PH, et al. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters. EuroIntervention 2012; 8(2): 205–213.
87 87 Okamura T, Onuma Y, García‐García HM, et al. 3‐Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification. JACC Cardiovasc Interv 2010; 3(8): 836–844.
88 88 Okamura T, Yamada J, Nao T, et al. Three‐dimensional optical coherence tomography assessment of coronary wire re‐crossing position during bifurcation stenting. EuroIntervention 2011; 7(7): 886–887.
89 89 Farooq V, Serruys PW, Heo JH, et al. New insights into the coronary artery bifurcation hypothesis‐generating concepts utilizing 3‐dimensional optical frequency domain imaging. JACC Cardiovasc Interv 2011; 4(8): 921–931.
90 90 Farooq V, Okamura T, Onuma Y, et al. Unravelling the complexities of the coronary bifurcation: is this raising a few eyebrows? EuroIntervention 2012; 7(10): 1133–1141.
91 91 Farooq V, Gogas BD, Okamura T, et al. Three‐dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical application. Eur Heart J 2013; 34(12): 875–885.
92 92 Okamura T, Onuma Y, Yamada J, et al. 3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting. EuroIntervention 2014; 10(8): 907–915.
93 93 Ferrante G, Kaplan AV, Di Mario C. Assessment with optical coherence tomography of a new strategy for bifurcational lesion treatment: the Tryton Side‐Branch Stent. Catheter Cardiovasc Interv 2009; 73(1): 69–72.
94 94 Beohar N, Kaltenbach LA, Wojdyla D, et al. Trends in Usage and Clinical Outcomes of Coronary Atherectomy: A Report From the National Cardiovascular Data Registry Cath PCI Registry. Circ Cardiovasc Interv. 2020 Feb; 13(2).
95 95 Shlofmitz E, Jeremias A, Shlofmitz R, Ali ZA. Lesion Preparation with Orbital Atherectomy. Interv Cardiol. 2019 Nov 18; 14(3):169–173
96 96 Mattesini A, Nargi G, Mattelini A et al. Intravascular imaging to guide lithotripsy in concentric and eccentric calcific coronary lesions. Cardiovascular Revascularization Medicine. Accepted for publication
97 97 Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus‐eluting stent: should we be cautious? Circulation 2004; 109(6): 701–705.
98 98 Templin C, Meyer M, Müller MF, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J 2010; 31(14): 1792–1801.
99 99 Malle C, Tada T, Steigerwald K, et al. Tissue characterization after drug‐eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol 2013; 33(6): 1376–1383.
100 100 Papayannis AC, Cipher D, Banerjee S, Brilakis ES. Optical coherence tomography evaluation of drug‐eluting stents: a systematic review. Catheter Cardiovasc Interv 2013; 81(3): 481–487.
101 101 Shlofmitz E, Iantorno M, Waksman R. Restenosis of Drug‐Eluting Stents. Circ. Cardiovasc. Interv. 2019, 12, e007023.
102 102 Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in‐stent restenosis. J Am Coll Cardiol 2014; 63(24): 2659–2673.
103 103 Gutiérrez‐Chico JL, Alegría‐Barrero E, Teijeiro‐Mestre R, et al. Optical coherence tomography: from research to practice. Eur Heart J Cardiovasc Imaging 2012; 13(5): 370–384.
104 104 Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography patterns of stent restenosis.